MT-RNR2 and early-onset autosomal dominant Alzheimer disease: Humanin can enhance cellular resistance to Alzheimer's disease-associated toxins such as β-amyloid, improve insulin sensitivity, prevent oxidative stress damage due to ischemia/reperfusion (I/R), hypoxia, or starvation, and increase the resistance to apoptosis [27, 28].